dihydropyridines and Hyperkalemia

dihydropyridines has been researched along with Hyperkalemia* in 1 studies

Other Studies

1 other study(ies) available for dihydropyridines and Hyperkalemia

Article	Year
Hyperkalemia induced by the calcium channel blocker, benidipine. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:6 A 73-year-old hypertensive, non-diabetic woman without obvious renal dysfunction had frequently been hyperkalemic over four years after receiving antihypertensive drugs including the calcium channel blocker (CCB) benidipine. One week after all medications were accidentally discontinued, the serum potassium level returned to normal. After we obtained the informed consent of the patient, benidipine alone was administered again for over two weeks and hyperkalemia developed once more. This previously uncommon side effect of hyperkalemia induced by benidipine is not very serious but it is apt to be overlooked. Since CCBs are now widely prescribed, the development of hyperkalemia should be considered. Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperkalemia; Hypertension; Risk Assessment; Severity of Illness Index	2003

Article

Year

Hyperkalemia induced by the calcium channel blocker, benidipine.

Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:6

A 73-year-old hypertensive, non-diabetic woman without obvious renal dysfunction had frequently been hyperkalemic over four years after receiving antihypertensive drugs including the calcium channel blocker (CCB) benidipine. One week after all medications were accidentally discontinued, the serum potassium level returned to normal. After we obtained the informed consent of the patient, benidipine alone was administered again for over two weeks and hyperkalemia developed once more. This previously uncommon side effect of hyperkalemia induced by benidipine is not very serious but it is apt to be overlooked. Since CCBs are now widely prescribed, the development of hyperkalemia should be considered.

Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperkalemia; Hypertension; Risk Assessment; Severity of Illness Index

2003